Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection

Published:2022 Issue:3 Volume:1 Page:393-402
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Maisonnasse Pauline,Poynard Thierry^ORCID,Sakka Mehdi,Akhavan Sepideh,Marlin Romain,Peta Valentina,Deckmyn Olivier,Ghedira Nesrine Braham,Ngo Yen,Rudler Marika,van der Werf Sylvie,Marot Stephane,Thabut Dominique,Sokol Harry,Housset Chantal,Combes Alain,Le Grand Roger,Cacoub Patrice

Funder

EIT Health

Publisher

Elsevier BV

Reference32 articles.

1. Proteomics and informatics for understanding phases and identifying biomarkers in COVID-19 disease;Whetton;J Proteome Res,2020

2. A time-resolved proteomic and prognostic map of COVID-19;Demichev;Cell Syst,2021

3. Performance of serum apolipoprotein-A1 as a sentinel of Covid-19;Poynard;PLoS One,2020

4. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease;Trinder;Arterioscler Thromb Vasc Biol,2020

5. U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies;Madsen;Eur Heart J,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative proteomic analysis and replacement therapy identifies haptoglobin as a therapeutic target in a murine model of SLE-associated diffuse alveolar hemorrhage;Frontiers in Veterinary Science;2024-08-12

2. Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients;PLOS ONE;2023-08-10

3. Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease;Cells;2023-06-10

4. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19;Biomedicines;2022-03-17